Align Technology Reports Third Quarter Earnings Results
The Tempe-based medical device manufacturer posts $1.01 billion in revenue for the recent period.
Updated on Oct. 28, 2026 in Corporate Finance
Live Poll
Does a company exceeding quarterly profit expectations make you more likely to trust its long-term stability?
Align Technology announced third-quarter earnings of $135 million, alongside total revenue reaching $1.01 billion. The company reported profits of $1.90 per share, with adjusted earnings coming in at $2.80 per share.
Why it matters
These results provide insight into the financial health of the Tempe-based company as it navigates market expectations. Comparing these figures against analyst projections helps investors gauge the firm's operational performance for the quarter.
Align Technology reported quarterly earnings of $135 million and adjusted earnings of $2.80 per share. The company generated $1.01 billion in revenue during the third-quarter period.
The players
Align Technology
Align Technology is a global medical device company headquartered in Tempe, Arizona, that designs and manufactures the Invisalign system.
The details
The earnings report reflects the company's financial standing at its Tempe headquarters. These results were calculated specifically for the third-quarter timeframe and compared against market benchmarks established by Zacks Investment Research.
Timeline
Align Technology reported its third-quarter earnings on October 28, 2026.
Market Dynamics
Align Technology's latest financial disclosure follows the established pattern of periodic performance reporting required for publicly traded companies within the healthcare sector. This filing contextualizes the company's growth trajectory relative to broader market cycles for medical device manufacturers.
Investors and shareholders may use these earnings figures to adjust their outlook on the company's stock, which has seen a 3% decrease year-to-date. The data serves as a key indicator for stakeholders evaluating the firm's long-term value against its 14% growth over the past year.
The takeaway
Understanding these quarterly metrics allows stakeholders to better track the company's progress in a competitive medical device market. Investors should monitor future earnings reports to see if the company can reverse its year-to-date share price decline.
Further reading
For additional context on local business developments, visit the Corporate Finance section.
Source note: This article includes information reported by WTOP.
Live Poll
Does a company exceeding quarterly profit expectations make you more likely to trust its long-term stability?
